I ask this question, because we need to plan and guide, vaccine manufacturers both in India and overseas to service the needs of our country in terms of procurement and distribution, Poonawalla said
Adar Poonawalla, CEO of the Serum Institute of India. Picture/ Twitter Adar Poonawalla
Rs 80,000 crore will be the cost of vaccinating everyone in India with the Covid-19 vaccine whenever it is available.
Adar Poonawalla, the CEO of the Serum Institute of India (SII) on Saturday asked the Indian government whether Rs 80,000 crore will be available over the next one year to buy the Covid vaccine and distribute it to everyone.
ADVERTISEMENT
SII is the world's largest manufacturer of vaccines and is conducting trials of Covid vaccine candidates like the AstraZeneca-Oxford vaccine.
"I ask this question, because we need to plan and guide, vaccine manufacturers both in India and overseas to service the needs of our country in terms of procurement and distribution," he (@adarpoonawalla) added.#COVID19vaccine #CovidVaccine pic.twitter.com/aOpQmpI9a4
— IANS Tweets (@ians_india) September 26, 2020
"Quick question: will the Government of India have 80,000 crores available over the next one year? Because that is what the Ministry of Health needs to buy and distribute the vaccine to everyone in India. This is the next concerning challenge we need to tackle," Poonawalla
said.
"I ask this question, because we need to plan and guide, vaccine manufacturers both in India and overseas to service the needs of our country in terms of procurement and distribution," he added.
Vaccine manufacturers intend to sell to governments who will then distribute and vaccinate the Covid vaccine. Poonawalla had told IANS
in an interview, "It is too early to comment on the vaccine's price.
However, we will keep it under Rs 1000. Having said that, our aim is to provide an efficacious and affordable vaccine. We are certain that it will be procured and distributed by governments without charge."
Poonawalla had said that as per the arrangement with AstraZeneca, SII will be making one billion doses of COVISHIELD over the next one year for India and other low-and-middle-income countries (GAVI countries).Once we get necessary regulatory approvals, we will start manufacturing in large volumes.
SII has said it will not take profit from the vaccine. "In the interest of public health and as one of the largest vaccine producers
it is our responsibility to make the vaccine affordable for the public at-large," he had said.
Keep scrolling to read more news
Catch up on all the latest Crime, National, International and Hatke news here. Also download the new mid-day Android and iOS apps to get latest updates.
Mid-Day is now on Telegram. Click here to join our channel (@middayinfomedialtd) and stay updated with the latest news
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever
Subscribe today by clicking the link and stay updated with the latest news!" Click here!
